HUT41737A - Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds - Google Patents
Process for preparing morphinane derivatives and pharmaceutical compositions containing such compoundsInfo
- Publication number
- HUT41737A HUT41737A HU861934A HU193486A HUT41737A HU T41737 A HUT41737 A HU T41737A HU 861934 A HU861934 A HU 861934A HU 193486 A HU193486 A HU 193486A HU T41737 A HUT41737 A HU T41737A
- Authority
- HU
- Hungary
- Prior art keywords
- preparing
- compounds
- pharmaceutical compositions
- compositions containing
- morphinane derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3518525 | 1985-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT41737A true HUT41737A (en) | 1987-05-28 |
| HU196376B HU196376B (en) | 1988-11-28 |
Family
ID=6271435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU861934A HU196376B (en) | 1985-05-23 | 1986-05-09 | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS61271275A (en) |
| AU (1) | AU594954B2 (en) |
| BE (1) | BE904796A (en) |
| DK (1) | DK240386A (en) |
| ES (1) | ES8802318A1 (en) |
| FI (1) | FI862124A (en) |
| FR (1) | FR2582309B1 (en) |
| GB (1) | GB2175898B (en) |
| GR (1) | GR861318B (en) |
| HU (1) | HU196376B (en) |
| IL (1) | IL78872A0 (en) |
| IT (1) | IT1203791B (en) |
| LU (1) | LU86435A1 (en) |
| NL (1) | NL8601188A (en) |
| NZ (1) | NZ216250A (en) |
| PH (1) | PH23341A (en) |
| SE (1) | SE8602308L (en) |
| ZA (1) | ZA863873B (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
| US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
| US4923875A (en) * | 1989-07-10 | 1990-05-08 | Baker Cummins Pharmaceuticals, Inc. | Method for treatment of mast cell-mediated dermatologic disorders |
| JP2906654B2 (en) * | 1989-11-28 | 1999-06-21 | 東レ株式会社 | Immunosuppressant and method for producing the same |
| US5057322A (en) * | 1990-08-10 | 1991-10-15 | Baker Cummins Dermatologicals, Inc. | Method of treating mast cell disease |
| EP0577847B1 (en) | 1992-01-23 | 1998-10-14 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
| WO1995003307A1 (en) * | 1993-07-19 | 1995-02-02 | Toray Industries, Inc. | Brain cell protective |
| AU686203B2 (en) * | 1993-07-23 | 1998-02-05 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
| TR199801348T2 (en) * | 1996-01-10 | 1998-10-21 | Smithkline Beecham S.P.A. | Heterosyclic condensate morphinoid t�revleri (II). |
| CN1180844C (en) * | 1996-11-25 | 2004-12-22 | 东丽株式会社 | Antipruritic agent |
| AU6117298A (en) * | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
| US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP5438250B2 (en) | 2002-05-17 | 2014-03-12 | ジェンケン バイオサイエンスィズ，インコーポレイテッド | Opioids and opioid-like compounds and their use |
| US7501433B2 (en) | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| JP4957489B2 (en) * | 2002-10-09 | 2012-06-20 | 東レ株式会社 | Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US8354534B2 (en) * | 2008-02-14 | 2013-01-15 | Alkermes, Inc. | Selective opioid compounds |
| WO2014091295A1 (en) * | 2012-12-14 | 2014-06-19 | Purdue Pharma L.P. | Pyridonemorphinan analogs and biological activity on opioid receptors |
| JP6141444B2 (en) * | 2012-12-14 | 2017-06-07 | パーデュー、ファーマ、リミテッド、パートナーシップ | Spirocyclic morphinans and their use |
| AR096851A1 (en) * | 2013-07-11 | 2016-02-03 | H Lundbeck As | SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO |
| WO2015192053A1 (en) * | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Azamophinan derivatives and use thereof |
-
1986
- 1986-05-09 HU HU861934A patent/HU196376B/en not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/en not_active Application Discontinuation
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-21 ES ES555200A patent/ES8802318A1/en not_active Expired
- 1986-05-21 FI FI862124A patent/FI862124A/en not_active Application Discontinuation
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-21 BE BE1/011493A patent/BE904796A/en not_active IP Right Cessation
- 1986-05-21 IL IL78872A patent/IL78872A0/en unknown
- 1986-05-21 SE SE8602308A patent/SE8602308L/en not_active Application Discontinuation
- 1986-05-21 GR GR861318A patent/GR861318B/en unknown
- 1986-05-22 JP JP61118984A patent/JPS61271275A/en active Pending
- 1986-05-22 DK DK240386A patent/DK240386A/en not_active Application Discontinuation
- 1986-05-22 LU LU86435A patent/LU86435A1/en unknown
- 1986-05-23 ZA ZA863873A patent/ZA863873B/en unknown
- 1986-05-23 FR FR8607367A patent/FR2582309B1/en not_active Expired
- 1986-05-23 IT IT48050/86A patent/IT1203791B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| DK240386A (en) | 1986-11-24 |
| ZA863873B (en) | 1988-01-27 |
| SE8602308D0 (en) | 1986-05-21 |
| FI862124A0 (en) | 1986-05-21 |
| ES8802318A1 (en) | 1988-05-01 |
| GB2175898B (en) | 1989-07-05 |
| BE904796A (en) | 1986-11-21 |
| GR861318B (en) | 1986-09-19 |
| JPS61271275A (en) | 1986-12-01 |
| IT8648050A0 (en) | 1986-05-23 |
| ES555200A0 (en) | 1988-05-01 |
| DK240386D0 (en) | 1986-05-22 |
| IL78872A0 (en) | 1986-09-30 |
| SE8602308L (en) | 1986-11-24 |
| IT1203791B (en) | 1989-02-23 |
| GB2175898A (en) | 1986-12-10 |
| PH23341A (en) | 1989-07-14 |
| FR2582309A1 (en) | 1986-11-28 |
| LU86435A1 (en) | 1986-12-05 |
| NZ216250A (en) | 1990-04-26 |
| FI862124A (en) | 1986-11-24 |
| FR2582309B1 (en) | 1989-08-18 |
| GB8612159D0 (en) | 1986-06-25 |
| NL8601188A (en) | 1986-12-16 |
| AU594954B2 (en) | 1990-03-22 |
| AU5763786A (en) | 1986-11-27 |
| HU196376B (en) | 1988-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT42101A (en) | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds | |
| HUT40625A (en) | Process for preparing dihydropyridine derivatives and pharmaceutical compositions containing such compounds | |
| HUT41790A (en) | Process for producing beta-amino-purine derivatives and pharmaceutical compositions containing them | |
| PT82463A (en) | Process for preparing novel aza-indole derivatives and pharmaceutical compositions therewith | |
| HUT42321A (en) | Process for preparing pharmaceutical compositions | |
| HUT41737A (en) | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds | |
| HUT38626A (en) | Process for preparing piperidine derivatives and pharmaceutical compositions containing such compounds | |
| HUT44512A (en) | Process for producing bensyl derivatives and pharmaceutical compositions containing them | |
| PT75815B (en) | Process for preparing morphinane derivatives and pharmaceutical compositions containing the same | |
| PT86365A (en) | Process for the preparation of pyridazodiazepine derivatives and of pharmaceutical compositions containing the same | |
| PT86516A (en) | Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same | |
| HUT42478A (en) | Process for producing gamma-carboline derivatives and pharmaceutical compositions containing them | |
| HUT40096A (en) | Process for preparing flavanone derivatives and pharmaceutical compositions containing such compounds | |
| HUT42774A (en) | Process for preparing spirodioxolane-, spirodithiolane and spirooxa-thiolane-derivatives and pharmaceutical compositions comprising such compounds | |
| PT82984A (en) | Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same | |
| HUT41035A (en) | Process for producing cepheme derivatives and pharmaceutical compositions containing them | |
| HUT41392A (en) | Process for producing new imidazolyl-alkyl-guanidine derivatives and pharmaceutical compositions containing them | |
| HUT38915A (en) | Process for preparing tricyclic dihydropiridazinone derivatives and pharmaceutical compositions containing such compounds as active substances | |
| HUT42488A (en) | Process for preparing beta-lactam derivatives and pharmaceutical compositions containing such compounds | |
| HUT47119A (en) | Process for producing 3-propenyl-cefem derivatives and pharmaceutical compositions comprising such compounds | |
| PT82395B (en) | Process for the preparation of synthetic derivatives of pseudopterosin and of pharmaceutical compositions containing the same | |
| PT82960A (en) | Process for preparing 5-substituted-6-amino-pyrimidine derivatives and pharmaceutical compositions containing them | |
| HUT41732A (en) | Process for preparing dihydro-pyridine derivatives and pharmaceutical compositions containing such compounds | |
| HUT44242A (en) | Process for preparing substituted toluidine-benzimidazole derivatives and pharmaceuticals comprising such compounds | |
| PT82464A (en) | Process for the preparation of novel benzisoselenazolonyl derivatives and of pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |